Take a look at how to shore up those international supply chain needs, the potential of interstate commerce under state-implemented Memoranda of Understanding, and the future of supply chain consistency in a post-legalized world.
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.
Join us for an update - from the comments that INCBA has submitted to the CDFA on behalf of the industry, to the most important aspects of the regulations, and what is necessary to make appellations of origin a functional tool for consumer education and choice in the cannabis industry.
This panel will address current and emerging challenges surrounding such methods and new products from the business, legal, and regulatory perspectives. Topics will include the vaping crisis, regulation of novel delivery systems, hardware inputs and related supply chain matters, various approaches to the regulation of edibles, hemp, and hemp-derived CBD, and what the future may hold.
Learn what is expected of you from the California Agencies, and use that as a template for your reopening no matter the jurisdictions. From providing PPE to social distancing, and spanning the obligations to your employees, customers, and the public at large, come to learn how to avoid liability and reopen safely and in accordance with the law.
Learn how to advise your clients to avoid additional scrutiny on the front end, how to prepare for an audit, and how to position your client for success post-audit. The panel will also take a look at novel state-level tax issues, such as a potency tax, and how that changes the bottom line for our clients.
Using the current regulatory landscape of CBD as a jumping-off point, this panel will explore this new market from a regulatory standpoint. We will discuss what these cannabinoids are and how they are likely to be used; whether they will encounter similar regulatory obstacles as CBD in coming to market; and whether we should continue to think of cannabinoids as a unified “block” for regulatory purposes,or if they will each have separate paths.
This panel will discuss the tactics states have adopted to keep people of color out of the industry along with resolutions. Attendees will leave the session knowledgeable about current equity policy impacts not only on retailers and indoor grow operations but rural communities of color.